This study aims to verify if patients with nerve-related leg pain benefits from neurodynamic treatment over two weeks.
Nerve-related leg pain (NRLP) although less prevalent than low back pain itself, is associated with higher economic and social burden, and has been considered a predictor of chronicity and disability among subjects with low back pain. Numerous approaches are proposed for its management; however, evidence regarding the best therapeutic approach is lacking. Neurodynamic techniques are proposed to be effective to manage NRLP. Thus, this study aims to verify, through a randomized controlled trial, the effectiveness of a two-week program of neurodynamic techniques on pain and disability in individuals with NRLP.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
All techniques will be executed in a pain-free way (grade III). Mild discomfort will be accepted, but it must subside as soon as the technique ends. * In the dynamic opener technique, patient will be positioned in side-lying, with the affected side upwards. The therapist will then perform grade III oscillations aiming to open the lumbar foramen; * In the side-lying slider, the patient will be in side-lying with the affected side upwards. A combination of knee and hip flexion and extension movements will produce sliding in the neural structures; * In the slump slider, the patient will be seated in slump position. Combinations between neck and knee movements will produce greater nerve excursion than the side-lying slider. Patients will perform the slump slider in a pain-free manner.
Federal University of Health Sciences of Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Leg Pain Intensity
Leg Pain will be measured by a 0-10 Numeric Rating Scale (Pain NRS)
Time frame: Two weeks after randomization
Disability
Disability will be measured by the Oswestry Disability Index (ODI)
Time frame: Two weeks after randomization
Leg pain Intensity
Leg Pain will me measured by a 0-10 Pain NRS
Time frame: Four weeks after randomization
Disability
Disability will be measured by the Oswestry Disability Index (ODI)
Time frame: Four weeks after randomization
Back pain intensity
Back Pain will me measured by an 0-10 Pain NRS
Time frame: Two weeks after randomization
Back pain intensity
Back Pain will me measured by an 0-10 Pain NRS
Time frame: Four weeks after randomization
Distribution of Symptoms
Distribution of symptoms will me measured by a body diagram
Time frame: Two weeks, Four weeks after randomization
Function
Function will be measured by the Patient-Specific Functional Scale (PSFS)
Time frame: Two weeks, Four weeks after randomization
Global Perceived Effect
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Global Perceived Effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale
Time frame: Two weeks, Four weeks after randomization